Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods

Adabi M., M. Talebi-Taher, L. Arbabi, M. Afshar, S. Fathizadeh, S. Minaeian, N. Moghadam-Maragheh and A. Majidpour. 2015. Spread of efflux pump overexpressing-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa by using an efflux pump inhibitor. Infect. Chemother. 47(2): 98–104.AdabiM.M.Talebi-TaherL.ArbabiM.AfsharS.FathizadehS.MinaeianN.Moghadam-MaraghehA.Majidpour2015Spread of efflux pump overexpressing-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa by using an efflux pump inhibitorInfect. Chemother.47(2):9810410.3947/ic.2015.47.2.98Search in Google Scholar

Al-Bakri A.G., G. Othman and Y. Bustanji. 2009. The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agents. J. Appl. Microbiol. 107(1): 280–286.Al-BakriA.G.G.OthmanY.Bustanji2009The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin-EDTA combination and their effectiveness as antibiofilm agentsJ. Appl. Microbiol.107(1):28028610.1111/j.1365-2672.2009.04205.xSearch in Google Scholar

Asok Kumar K., K. Mazumdar, N.K. Dutta, P. Karak, S.G. Dastidar and R. Ray. 2004. Evaluation of synergism between the aminoglycoside antibiotic streptomycin and the cardiovascular agent amlodipine. Biol. Pharm. Bull. 27(7): 1116–1120.Asok KumarK.K.MazumdarN.K.DuttaP.KarakS.G.DastidarR.Ray2004Evaluation of synergism between the aminoglycoside antibiotic streptomycin and the cardiovascular agent amlodipineBiol. Pharm. Bull.27(7):1116112010.1248/bpb.27.1116Search in Google Scholar

Axon J.M.C. and E.C. Huskisson 1992. Use of aspirin in inflammatory diseases, pp. 295–320. In: Vane J.R. and R.M. Botting (eds). Aspirin and Other Salicylates. Chapman and Hall, London (United Kingdom).AxonJ.M.C.E.C.Huskisson1992Use of aspirin in inflammatory diseases,pp. 295320.In:VaneJ.R.R.M.Botting(eds).Aspirin and Other SalicylatesChapman and HallLondon (United Kingdom)Search in Google Scholar

Bazyleu A. and A. Kumar. 2014. Incubation temperature, osmolarity, and salicylate affect the expression of resistance-nodulation-division efflux pumps and outer membrane porins in Acinetobacter baumannii ATCC 19606T. FEMS Microbiol. Lett. 357(2): 136–143.BazyleuA.A.Kumar2014Incubation temperature, osmolarity, and salicylate affect the expression of resistance-nodulation-division efflux pumps and outer membrane porins in Acinetobacter baumannii ATCC 19606TFEMS Microbiol. Lett.357(2):136143Search in Google Scholar

Bown R.L. 2002. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole. Int. J. Clin. Pract. 56(2): 132–139.BownR.L.2002An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazoleInt. J. Clin. Pract.56(2):132139Search in Google Scholar

Cohen S.P., S.B. Levy, J. Foulds and J.L. Rosner. 1993. Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. J. Bacteriol. 175(24): 7856–7862.CohenS.P.S.B.LevyJ.FouldsJ.L.Rosner1993Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathwayJ. Bacteriol.175(24):7856786210.1128/jb.175.24.7856-7862.1993Search in Google Scholar

Dastidar S.G., K. Ganguly, K. Chaudhuri and A.N. Chakrabarty. 2000. The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. Int. J. Antimicrob. Agents. 14(3): 249–251.DastidarS.G.K.GangulyK.ChaudhuriA.N.Chakrabarty2000The anti-bacterial action of diclofenac shown by inhibition of DNA synthesisInt. J. Antimicrob. Agents.14(3):24925110.1016/S0924-8579(99)00159-4Search in Google Scholar

Dasgupta A., S. Chaki, S. Mukherjee, J. Lourduraja, K. Mazumdar, N.K. Dutta and S.G. Dastidar. 2010. Experimental analyses of synergistic combinations of antibiotics with a recently recognised antibacterial agent, lacidipine. Eur. J. Clin. Microbiol. Infect. Dis. 29(2): 239–243.DasguptaA.S.ChakiS.MukherjeeJ.LourdurajaK.MazumdarN.K.DuttaS.G.Dastidar2010Experimental analyses of synergistic combinations of antibiotics with a recently recognised antibacterial agent, lacidipineEur. J. Clin. Microbiol. Infect. Dis.29(2):23924310.1007/s10096-009-0845-y20012879Search in Google Scholar

Domenico P., T. Hopkins and B.A. Cunha. 1990. The effect of sodium salicylate on antibiotic susceptibility and synergy in Klebsiella pneumoniae. J. Antimicrob. Chemother. 26(3): 343–351.DomenicoP.T.HopkinsB.A.Cunha1990The effect of sodium salicylate on antibiotic susceptibility and synergy in Klebsiella pneumoniaeJ. Antimicrob. Chemother.26(3):34335110.1093/jac/26.3.3432228825Search in Google Scholar

Dutta N.K., S. Annadurai, K. Mazumdar, S.G. Dastidar, J.E. Kristiansen, J. Molnar, M. Martins and L. Amaral. 2007. Potential management of resistant microbial infections with a novel nonantibiotic: the anti-inflammatory drug diclofenac sodium. Int. J. Antimicrob. Agents. 30(3): 242–249.DuttaN.K.S.AnnaduraiK.MazumdarS.G.DastidarJ.E.KristiansenJ.MolnarM.MartinsL.Amaral2007Potential management of resistant microbial infections with a novel nonantibiotic: the anti-inflammatory drug diclofenac sodiumInt. J. Antimicrob. Agents.30(3):24224910.1016/j.ijantimicag.2007.04.01817644318Search in Google Scholar

Farha M.A., A. Leung, E.W. Sewell, M.A. D’Elia, S.E. Allison, L. Ejim, P.M. Pereira, M.G. Pinho, G.D. Wright and E.D. Brown. 2013. Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactams. ACS Chem. Biol. 8(1): 226–233.FarhaM.A.A.LeungE.W.SewellM.A.D’EliaS.E.AllisonL.EjimP.M.PereiraM.G.PinhoG.D.WrightE.D.Brown2013Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to β-lactamsACS Chem. Biol.8(1):22623310.1021/cb300413m355248523062620Search in Google Scholar

Foulds J., D.M. Murray, T. Chai and J.L. Rosner. 1989. Decreased permeation of cephalosporins through the outer membrane of Escherichia coli grown in salicylates. Antimicrob. Agents Chemother. 33(4): 412–417.FouldsJ.D.M.MurrayT.ChaiJ.L.Rosner1989Decreased permeation of cephalosporins through the outer membrane of Escherichia coli grown in salicylatesAntimicrob. Agents Chemother.33(4):41241710.1128/AAC.33.4.4121724512658790Search in Google Scholar

Frantz B. and E.A. O’Neill. 1995. The effect of sodium salicylate and aspirin on NF-kappa B. Science 270(5244): 2017–2019.FrantzB.E.A.O’Neill1995The effect of sodium salicylate and aspirin on NF-kappa BScience270(5244):2017201910.1126/science.270.5244.2017Search in Google Scholar

Grkovic S., M.H. Brown and R.A. Skurray 2002. Regulation of bacterial drug export systems. Microbiol. Mol. Biol. Rev. 66 (4): 671–701.GrkovicS.M.H.BrownR.A.Skurray2002Regulation of bacterial drug export systemsMicrobiol. Mol. Biol. Rev.66(4):67170110.1128/MMBR.66.4.671-701.2002Search in Google Scholar

Hartog E., O. Menashe, E. Kler and S. Yaron. 2010. Salicylate reduces the antimicrobial activity of ciprofloxacin against extracellular Salmonella enterica serovar Typhimurium, but not against Salmonella in macrophages. J. Antimicrob. Chemother. 65(5): 888–896.HartogE.O.MenasheE.KlerS.Yaron2010Salicylate reduces the antimicrobial activity of ciprofloxacin against extracellular Salmonella enterica serovar Typhimurium, but not against Salmonella in macrophagesJ. Antimicrob. Chemother.65(5):88889610.1093/jac/dkq077Search in Google Scholar

Hendricks O., T.S. Butterworth and J.E. Kristiansen. 2003. The in vitro antimicrobial effect of non-antibiotics and putative inhibitors of efflux pumps on Pseudomonas aeruginosa and Staphylococcus aureus. Int. J. Antimicrob. Agents. 22(3): 262–264.HendricksO.T.S.ButterworthJ.E.Kristiansen2003The in vitro antimicrobial effect of non-antibiotics and putative inhibitors of efflux pumps on Pseudomonas aeruginosa and Staphylococcus aureusInt. J. Antimicrob. Agents.22(3):26226410.1016/S0924-8579(03)00205-XSearch in Google Scholar

Huang Y.W., R.M. Hu, F.Y. Chu, H.R. Lin and T.C. Yang. 2013. Characterization of a major facilitator superfamily (MFS) tripartite efflux pump EmrCABsm from Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 68(11): 2498–2505.HuangY.W.R.M.HuF.Y.ChuH.R.LinT.C.Yang2013Characterization of a major facilitator superfamily (MFS) tripartite efflux pump EmrCABsm from Stenotrophomonas maltophiliaJ. Antimicrob. Chemother.68(11):2498250510.1093/jac/dkt250Search in Google Scholar

Kim H.B., M. Wang, C.H. Park, E.C. Kim, G.A. Jacoby and D.C. Hooper. 2009. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob. Agents Chemother. 53(8): 3582–3584.KimH.B.M.WangC.H.ParkE.C.KimG.A.JacobyD.C.Hooper2009oqxAB encoding a multidrug efflux pump in human clinical isolates of EnterobacteriaceaeAntimicrob. Agents Chemother.53(8):3582358410.1128/AAC.01574-08Search in Google Scholar

Kriengkauykiat J., E. Porter, O. Lomovskaya and A. Wong-Beringer. 2005. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49(2): 565–570.KriengkauykiatJ.E.PorterO.LomovskayaA.Wong-Beringer2005Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosaAntimicrob. Agents Chemother.49(2):56557010.1128/AAC.49.2.565-570.2005Search in Google Scholar

Kristiansen J.E., O. Hendricks, T. Delvin, T.S. Butterworth, L. Aagaard, J.B. Christensen, V.C. Flores and H. Keyzer. 2007. Reversal of resistance in microorganisms by help of non-antibiotics. J. Antimicrob. Chemother. 59(6): 1271–1279.KristiansenJ.E.O.HendricksT.DelvinT.S.ButterworthL.AagaardJ.B.ChristensenV.C.FloresH.Keyzer2007Reversal of resistance in microorganisms by help of non-antibioticsJ. Antimicrob. Chemother.59(6):1271127910.1093/jac/dkm071Search in Google Scholar

Kristiansen J.E., V.F. Thomsen, A. Martines, M. Viveiros and L. Amaral. 2010. Non-antibiotics reverse resistance of bacteria to antibiotics. In Vivo. 24(5): 751–754.KristiansenJ.E.V.F.ThomsenA.MartinesM.ViveirosL.Amaral2010Non-antibiotics reverse resistance of bacteria to antibioticsIn Vivo.24(5):751754Search in Google Scholar

Kruszewska H., T. Zaręba and S. Tyski. 2002. Search of antimicrobial activity of selected non-antibiotics drugs. Acta Pol. Pharm. Drug Res. 59(6): 436–439.KruszewskaH.T.ZarębaS.Tyski2002Search of antimicrobial activity of selected non-antibiotics drugsActa Pol. Pharm. Drug Res.59(6):436439Search in Google Scholar

Kruszewska H., T. Zaręba and S. Tyski. 2004. Examination of antimicrobial activity of selected non-antibiotics drugs. Acta Pol. Pharm. Drug Res. 61(Suppl. 5): 18–21.KruszewskaH.T.ZarębaS.Tyski2004Examination of antimicrobial activity of selected non-antibiotics drugsActa Pol. Pharm. Drug Res.61(Suppl. 5)1821Search in Google Scholar

Kruszewska H., T. Zaręba and S. Tyski. 2008. Examination of antibacterial and antifungal activity of selected non-antibiotic products. Acta Pol. Pharm. Drug Res. 65(6): 779–782.KruszewskaH.T.ZarębaS.Tyski2008Examination of antibacterial and antifungal activity of selected non-antibiotic productsActa Pol. Pharm. Drug Res.65(6):779782Search in Google Scholar

Kruszewska H., T. Zaręba and S. Tyski. 2010. Examination of antimicrobial activity of selected non-antibiotic products. Acta Pol. Pharm. Drug Res. 67(6): 733–736.KruszewskaH.T.ZarębaS.Tyski2010Examination of antimicrobial activity of selected non-antibiotic productsActa Pol. Pharm. Drug Res.67(6):733736Search in Google Scholar

Kubo I., K. Fujita, K. Nihei and N. Masuoka. 2003. Non-antibiotic antibacterial activity of dodecyl gallate. Bioorg. Med. Chem. 11(4): 573–580.KuboI.K.FujitaK.NiheiN.Masuoka2003Non-antibiotic antibacterial activity of dodecyl gallateBioorg. Med. Chem.11(4):57358010.1016/S0968-0896(02)00436-4Search in Google Scholar

Lomovskaya O., K. Lewis and A. Matin. 1995. EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J. Bacteriol. 177(9): 2328–2334.LomovskayaO.K.LewisA.Matin1995EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrABJ. Bacteriol.177(9):2328233410.1128/jb.177.9.2328-2334.19951768887730261Search in Google Scholar

Lomovskaya O., M.S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Ckamberland, T. Renau and others. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45(1): 105–116.LomovskayaO.M.S.WarrenA.LeeJ.GalazzoR.FronkoM.LeeJ.BlaisD.ChoS.CkamberlandT.Renauand others2001Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapyAntimicrob. Agents Chemother.45(1):10511610.1128/AAC.45.1.105-116.20019024711120952Search in Google Scholar

Laudy A.E. 2008. MDR efflux pumps – the mechanism of Gram-negative rods resistance to antibiotics. Post. Mikrobiol. 47(3): 415–422.LaudyA.E.2008MDR efflux pumps – the mechanism of Gram-negative rods resistance to antibioticsPost. Mikrobiol.47(3):415422Search in Google Scholar

Laudy A.E., E. Kulińska and S. Tyski. 2017. The impact of efflux pump inhibitors on the activity of selected non-antibiotic medicinal products against Gram-negative bacteria. Molecules. 22(1): E114. doi:10.3390/molecules22010114.LaudyA.E.E.KulińskaS.Tyski2017The impact of efflux pump inhibitors on the activity of selected non-antibiotic medicinal products against Gram-negative bacteriaMolecules.22(1):E114.doi:10.3390/molecules22010114Open DOISearch in Google Scholar

Laudy A.E., A. Mrówka, J. Krajewska and S. Tyski. 2016. The influence of efflux pump inhibitors on the activity of non-antibiotic NSAIDS against Gram-Negative rods. PLoS ONE. 11(1): e0147131. doi:10.1371/journal.pone.0147131.LaudyA.E.A.MrówkaJ.KrajewskaS.Tyski2016The influence of efflux pump inhibitors on the activity of non-antibiotic NSAIDS against Gram-Negative rodsPLoS ONE.11(1):e0147131.doi:10.1371/journal.pone.0147131Open DOISearch in Google Scholar

Laudy A.E., P. Osińska, A. Namysłowska, O. Zając and S. Tyski. 2015. Modification of the susceptibility of Gram-negative rods producing ESβLs to β-lactams by the efflux phenomenon. PLoS ONE. 10(3): e0119997. doi:10.1371/journal.pone.0119997.LaudyA.E.P.OsińskaA.NamysłowskaO.ZającS.Tyski2015Modification of the susceptibility of Gram-negative rods producing ESβLs to β-lactams by the efflux phenomenonPLoS ONE.10(3):e0119997.doi:10.1371/journal.pone.0119997Open DOISearch in Google Scholar

Li X.Z., P. Plesiat and H. Nikaido. 2015. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28(2): 337–418.LiX.Z.P.PlesiatH.Nikaido2015The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteriaClin. Microbiol. Rev.28(2):33741810.1128/CMR.00117-14440295225788514Search in Google Scholar

Martins M., S.G. Dastidar, S. Fanning, J.E. Kristiansen, J. Molnar, J.M. Pages, Z. Schelz, G. Spengler, M. Viveros and L. Amaral. 2008. Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities. Int. J. Antimicrob. Agents. 31(3): 198–208.MartinsM.S.G.DastidarS.FanningJ.E.KristiansenJ.MolnarJ.M.PagesZ.SchelzG.SpenglerM.ViverosL.Amaral2008Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activitiesInt. J. Antimicrob. Agents.31(3):19820810.1016/j.ijantimicag.2007.10.02518180147Search in Google Scholar

Mazumdar K., K. Asok Kumar and N.K. Dutta. 2010. Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: Scope and hope for the future. Int. J. Antimicrob. Agents. 36(4): 295–302.MazumdarK.K.Asok KumarN.K.Dutta2010Potential role of the cardiovascular non-antibiotic (helper compound) amlodipine in the treatment of microbial infections: Scope and hope for the futureInt. J. Antimicrob. Agents.36(4):29530210.1016/j.ijantimicag.2010.05.00320591629Search in Google Scholar

Mazumdar K., N.K. Dutta, S.G. Dastidar, N. Motohashi and Y. Shirataki. 2006. Diclofenac in the management of E. coli urinary tract infections. In Vivo 20(5): 613–620.MazumdarK.N.K.DuttaS.G.DastidarN.MotohashiY.Shirataki2006Diclofenac in the management of E. coli urinary tract infectionsIn Vivo20(5):613620Search in Google Scholar

Mazumdar K., N.K. Dutta, K.A. Kumar and S.G. Dastidar. 2005. In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains. Biol. Pharm. Bull. 28(4): 713–717.MazumdarK.N.K.DuttaK.A.KumarS.G.Dastidar2005In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strainsBiol. Pharm. Bull.28(4):71371710.1248/bpb.28.71315802815Search in Google Scholar

Miriagou V., G. Cornaglia, M. Edelstein, I. Galani, C.G. Giske, M. Gniadkowski, E. Malamou-Lada, L. Martinez-Martinez, F. Navarro, P. Nordmann and others. 2010. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin. Microbiol. Infect. 16(2): 112–122.MiriagouV.G.CornagliaM.EdelsteinI.GalaniC.G.GiskeM.GniadkowskiE.Malamou-LadaL.Martinez-MartinezF.NavarroP.Nordmannand others2010Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issuesClin. Microbiol. Infect.16(2):11212210.1111/j.1469-0691.2009.03116.x20085605Search in Google Scholar

Nair B.M., K.J. Cheung Jr., A. Griffith and J.L. Burns. 2004. Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J. Clin. Invest. 113(3): 464–473.NairB.M.K.J.CheungJr.A.GriffithJ.L.Burns2004Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia)J. Clin. Invest.113(3):46447310.1172/JCI200419710Search in Google Scholar

Needs C.J. and P.M. Brooks. 1985. Clinical pharmacokinetics of the salicylates. Clin. Pharmacokinet. 10(2): 164–177.NeedsC.J.P.M.Brooks1985Clinical pharmacokinetics of the salicylatesClin. Pharmacokinet.10(2):16417710.2165/00003088-198510020-00004Search in Google Scholar

Nikaido H. and J.M. Pages. 2012. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol. Rev. 36(2): 340–363.NikaidoH.J.M.Pages2012Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteriaFEMS Microbiol. Rev.36(2):34036310.1111/j.1574-6976.2011.00290.xSearch in Google Scholar

Pagès J.M. and L. Amaral. 2009. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim. Biophys. Acta. 1794(5): 826–833.PagèsJ.M.L.Amaral2009Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteriaBiochim. Biophys. Acta.1794(5):82683310.1016/j.bbapap.2008.12.011Search in Google Scholar

Piddock L.J. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19(2): 382–402.PiddockL.J.2006Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteriaClin. Microbiol. Rev.19(2):38240210.1128/CMR.19.2.382-402.2006Search in Google Scholar

Poirel L., R.A. Bonnin and P. Nordmann. 2012. Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods. Infect. Genet. Evol. 12(5): 883–893.PoirelL.R.A.BonninP.Nordmann2012Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rodsInfect. Genet. Evol.12(5):88389310.1016/j.meegid.2012.02.008Search in Google Scholar

Price C.T., I.R. Lee and J.E. Gustafson. 2000. The effects of salicylate on bacteria. Int. J. Biochem. Cell Biol. 32(10): 1029–1043.PriceC.T.I.R.LeeJ.E.Gustafson2000The effects of salicylate on bacteriaInt. J. Biochem. Cell Biol.32(10):1029104310.1016/S1357-2725(00)00042-XSearch in Google Scholar

Shirin H., S.F. Moss, S. Kancherla, K. Kancherla, P.R. Holt, I.B. Weinstein and E.M. Sordillo. 2006. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori. J. Gastroenterol. Hepatol. 21(9): 1388–1393.ShirinH.S.F.MossS.KancherlaK.KancherlaP.R.HoltI.B.WeinsteinE.M.Sordillo2006Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pyloriJ. Gastroenterol. Hepatol.21(9):13881393Search in Google Scholar

Rosner J.L. 1985. Nonheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12. Proc. Natl. Acad. Sci. USA 82(24): 8771–8774.RosnerJ.L.1985Nonheritable resistance to chloramphenicol and other antibiotics induced by salicylates and other chemotactic repellents in Escherichia coli K-12Proc. Natl. Acad. Sci. USA82(24):8771877410.1073/pnas.82.24.87713915193909154Search in Google Scholar

Tanabe H., K. Yamasak, M. Furue, K. Yamamoto, A. Katoh, M. Yamamoto, S. Yoshioka, H. Tagami, H.A. Aiba and R. Utsumi. 1997. Growth phase-dependent transcription of emrKY, a homolog of multidrug efflux emrAB genes of Escherichia coli, is induced by tetracycline. J. Gen. Appl. Microbiol. 43(5): 257–263.TanabeH.K.YamasakM.FurueK.YamamotoA.KatohM.YamamotoS.YoshiokaH.TagamiH.A.AibaR.Utsumi1997Growth phase-dependent transcription of emrKY, a homolog of multidrug efflux emrAB genes of Escherichia coli, is induced by tetracyclineJ. Gen. Appl. Microbiol.43(5):25726310.2323/jgam.43.25712501312Search in Google Scholar

Tamanai-Shacoori Z., V. Shacoori, A. Jolivet-Gougeon, J.M. Vo Van, M. Repere, P. Donnio and M. Bonnaure-Mallet. 2007. The antibacterial activity of tramadol against bacteria associated with infectious complications after local or regional anesthesia. Anesth. Analg. 105(2): 524–527.Tamanai-ShacooriZ.V.ShacooriA.Jolivet-GougeonJ.M.Vo VanM.RepereP.DonnioM.Bonnaure-Mallet2007The antibacterial activity of tramadol against bacteria associated with infectious complications after local or regional anesthesiaAnesth. Analg.105(2):52452710.1213/01.ane.0000267525.51017.b817646517Search in Google Scholar

Wang W.H., W.M. Wong, D. Dailidiene, D.E. Berg, Q. Gu, K.C. Lai, S.K. Lam and B.C. Wong. 2003. Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents. Gut. 52(4): 490–495.WangW.H.W.M.WongD.DailidieneD.E.BergQ.GuK.C.LaiS.K.LamB.C.Wong2003Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agentsGut.52(4):49049510.1136/gut.52.4.490177358112631656Search in Google Scholar

WHO (World Health Organization). 2017. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. http://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1, 2018.03.24.WHO (World Health Organization)2017Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibioticshttp://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf?ua=1, 2018.03.24Search in Google Scholar

Wu K.K. 2000. Aspirin and salicylate, an old remedy with a new twist. Circulation. 102(17): 2022–2023.WuK.K.2000Aspirin and salicylate, an old remedy with a new twistCirculation.102(17):2022202310.1161/01.CIR.102.17.2022Search in Google Scholar

Yamane K., J. Wachino, S. Suzuki and Y. Arakawa. 2008. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 52(4): 1564–1566.YamaneK.J.WachinoS.SuzukiY.Arakawa2008Plasmid-mediated qepA gene among Escherichia coli clinical isolates from JapanAntimicrob. Agents Chemother.52(4):1564156610.1128/AAC.01137-07229254318285488Search in Google Scholar

Yin Z., Y. Wang, L.R. Whittell, S. Jergic, M. Liu, E. Harry, N.E. Dixon, M.J. Kelso, J.L. Beck and A.J. Oakley. 2014. DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugs. Chem. Biol. 21(4): 481–487.YinZ.Y.WangL.R.WhittellS.JergicM.LiuE.HarryN.E.DixonM.J.KelsoJ.L.BeckA.J.Oakley2014DNA replication is the target for the antibacterial effects of nonsteroidal anti-inflammatory drugsChem. Biol.21(4):48148710.1016/j.chembiol.2014.02.00924631121Search in Google Scholar